Cover Image
市場調查報告書

美國的肥胖外科手術用設備市場預測

United States Bariatric Surgery Devices Market Outlook to 2023

出版商 GlobalData 商品編碼 307140
出版日期 內容資訊 英文 75 Pages
訂單完成後即時交付
價格
Back to Top
美國的肥胖外科手術用設備市場預測 United States Bariatric Surgery Devices Market Outlook to 2023
出版日期: 2017年03月06日 內容資訊: 英文 75 Pages
簡介

本報告提供美國的肥胖外科手術用設備市場相關的減重手術用縫合器,胃束帶,胃水球等類別銷售額,銷售數的實際成果及預測,平均價格,企業佔有率,流通佔有率,再加上主要企業簡介,開發中產品,主要的財務相關交易之最新資訊等資料。

第1章 目錄

第2章 簡介

  • 報告的內容
  • 肥胖外科手術用設備市場區分
  • 該報告對象的市場定義

第3章 美國的肥胖外科手術用設備市場

  • 收益(實際成果)
  • 收益(預測)
  • 銷售數(實際成果)
  • 銷售數(預測)
  • 平均價格
  • 流通佔有率:各收益
  • 企業佔有率:各收益

第4章 主要企業概要

  • Covidien plc
  • Ethicon Endo-Surgery, Inc.
  • Allergan, Inc.

第5章 開發中產品

第6章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

GlobalData's new report, "United States Bariatric Surgery Devices Market Outlook to 2023", provides key market data on the United States Bariatric Surgery Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Bariatric Stapling Devices, Gastric Bands and Gastric Balloons.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Bariatric Surgery Devices market segments - Bariatric Stapling Devices, Gastric Bands and Gastric Balloons.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Bariatric Surgery Devices market.
  • Key players covered include Medtronic plc, Ethicon Inc and Others.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 5
  • 1.2 List of Figures 5

2 Introduction 6

  • 2.1 What Is This Report About? 6
  • 2.2 Bariatric Surgery Devices Market Segmentation 6
  • 2.3 Definitions of Markets Covered in the Report 7

3 Bariatric Surgery Devices Market, United States 8

  • 3.1 Bariatric Surgery Devices Market, United States, Revenue ($m), 2009-2016 8
  • 3.2 Bariatric Surgery Devices Market, United States, Revenue ($m), 2016-2023 10
  • 3.3 Bariatric Surgery Devices Market, United States, Volume (Units), 2009-2016 12
  • 3.4 Bariatric Surgery Devices Market, United States, Volume (Units), 2016-2023 14
  • 3.5 Bariatric Surgery Devices Market, United States, Average Price ($), 2009-2023 16
  • 3.6 Bariatric Surgery Devices Market, United States, Distribution Share by Revenue ($m), 2016 17
  • 3.7 Bariatric Surgery Devices Market, United States, Company Share by Revenue ($m), 2016 18

4 Overview of Key Companies in United States, Bariatric Surgery Devices Market 19

  • 4.1 Medtronic Plc 19
    • 4.1.1 Company Overview 19
  • 4.2 Ethicon Inc 19
    • 4.2.1 Company Overview 19
  • 4.3 Apollo Endosurgery Inc 19
    • 4.3.1 Company Overview 19

5 Bariatric Surgery Devices Market Pipeline Products 20

6 Financial Deals Landscape 21

  • 6.1 Acquisition 21
    • 6.1.1 Allergan to Acquire Zeltiq Aesthetics for USD2.48 Billion 21
    • 6.1.2 Confluent Medical Technologies Acquires ETE Medical 23
  • 6.2 Equity Offerings 25
    • 6.2.1 EnteroMedics Raises USD19 Million in Public Offering of Units 25
    • 6.2.2 TransEnterix Plans to Raise up to USD25 Million in Private Placement of Shares 27
    • 6.2.3 GI Dynamics to Raise up to USD0.7 Million in Security Purchase Plan of CDIs 28
    • 6.2.4 Obalon Therapeutics Prices IPO for USD75 Million 29
  • 6.3 Venture Financing 31
    • 6.3.1 Reshape Medical Raises USD11 Million in Venture Financing 31
    • 6.3.2 Allurion Tech Raises USD19 Million in Venture Financing 32
    • 6.3.3 MetaModix Raises USD0.1 Million in Venture Financing 33
    • 6.3.4 Standard Bariatrics Raises Funds through Seed Financing 34
    • 6.3.5 Aspire Bariatrics Raises USD3.6 Million in Venture Financing 35
    • 6.3.6 MetaModix Raises USD0.1 Million in Financing 36

7 Recent Developments 37

  • 7.1 Corporate Communications 37
    • 7.1.1 Jan 17, 2017: Apollo Endosurgery Appoints Dr. Christopher J. Gostout as Chief Medical Officer 37
    • 7.1.2 Jan 17, 2017: Jonah Shacknai Joins Obalon Therapeutics Board of Directors 37
    • 7.1.3 Jan 09, 2017: ZELTIQ Aesthetics Announces Commercial Leadership Transition 38
    • 7.1.4 Jan 05, 2017: GI Dynamics Appoints Oern R. Stuge, MD, Amid Change to Company's Board of Directors 38
    • 7.1.5 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 39
    • 7.1.6 Sep 27, 2016: EnteroMedics Announces Appointment of Dan Gladney as Chairman of the Board of Directors 40
    • 7.1.7 Sep 07, 2016: EnteroMedics Announces Appointment of Scott Youngstrom as Chief Financial Officer and Chief Compliance Officer 40
    • 7.1.8 Sep 02, 2016: Gelesis Appoints New Chief Operating Officer 41
    • 7.1.9 Aug 22, 2016: Vizient Announces Aaron Gerber, M.D. as the Newly Appointed President of Sg2 41
    • 7.1.10 Aug 22, 2016: Vizient Announces Aaron Gerber, M.D. as the Newly Appointed President of Sg2 42
    • 7.1.11 Aug 17, 2016: EnteroMedics Announces Appointment of Gary Blackford to its Board of Directors 42
    • 7.1.12 Aug 08, 2016: ReShape Medical Announces the Appointment of Michael J. Mangano as President and Chief Executive Officer 43
    • 7.1.13 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors 43
    • 7.1.14 Jun 27, 2016: Vizient Announces New Members to its Board of Directors 44
    • 7.1.15 May 25, 2016: TransEnterix Appoints Theodore Pappas, MD Senior Surgical Officer 44
    • 7.1.16 May 10, 2016: GI Dynamics Appoints Chief Compliance Officer 45
    • 7.1.17 May 05, 2016: GI Dynamics Appoints Chief Financial Officer 45
    • 7.1.18 May 04, 2016: BAROnova Announces Appointment of David S. Thrower as President and Chief Executive Officer 46
    • 7.1.19 May 03, 2016: GI Dynamics: Daniel J. Moore Elected Chairman of the Board 46
    • 7.1.20 Apr 26, 2016: Hospira President, David J. Endicott, Joins ZELTIQ Aesthetics Board of Directors 47
    • 7.1.21 Mar 23, 2016: GI Dynamics Announces the Appointment of Medical Device Industry Veteran Scott Schorer as President & Chief Executive Officer 48
  • 7.2 Financial Announcements 48
    • 7.2.1 Feb 23, 2017: Obalon Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results 48
    • 7.2.2 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 49
    • 7.2.3 Jan 31, 2017: GI Dynamics: Quarterly Report - Quarter Ended 31 December 2016 50
    • 7.2.4 Jan 26, 2017: Bard Announces Fourth Quarter Results 50
    • 7.2.5 Jan 09, 2017: ZELTIQ Reports Preliminary Fourth Quarter and Full Year 2016 Revenue and Provides 2017 Guidance 51
    • 7.2.6 Nov 11, 2016: Obalon Therapeutics Announces Third Quarter Financial Results 52
    • 7.2.7 Nov 09, 2016: TransEnterix Reports Operating Results for the Third Quarter 2016 53
    • 7.2.8 Nov 09, 2016: ZELTIQ Announces Third Quarter 2016 Financial Results 53
    • 7.2.9 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 54
    • 7.2.10 Oct 25, 2016: Bard Announces Third Quarter Results 55
    • 7.2.11 Aug 08, 2016: ZELTIQ Announces Second Quarter 2016 Financial Results 56
    • 7.2.12 Aug 05, 2016: TransEnterix Reports Operating Results for the Second Quarter 2016 57
    • 7.2.13 Aug 04, 2016: EnteroMedics Reports Second Quarter 2016 Financial Results 58
    • 7.2.14 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016 58
    • 7.2.15 Jul 28, 2016: GI Dynamics: Appendix 4C: Quarter ended 30 June 2016 60
    • 7.2.16 Jul 26, 2016: Bard Announces Second Quarter Results 61
    • 7.2.17 May 10, 2016: TransEnterix Reports Operating Results for the First Quarter 2016 61
    • 7.2.18 May 10, 2016: ZELTIQ Announces First Quarter 2016 Financial Results 62
  • 7.3 Other Significant Developments 63
    • 7.3.1 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 63
    • 7.3.2 Jan 24, 2017: Mayo Clinic Selects Vizient as Its Performance Improvement Partner 64
    • 7.3.3 Jan 11, 2017: GI Dynamics Provides 2017 Business Outlook and 2016 Review 64
    • 7.3.4 Nov 22, 2016: EnteroMedics Provides Commercialization and Corporate Update 65
    • 7.3.5 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation 66
    • 7.3.6 May 02, 2016: EnteroMedics Announces Exclusive Federal Government Business Channel Sales Agreement with Academy Medical to Provide vBloc Neurometabolic Therapy 66
    • 7.3.7 Apr 07, 2016: Response Biomedical Awarded Capital Equipment Supplier Contract by Vizient 67
  • 7.4 Product News 67
    • 7.4.1 Feb 09, 2017: EnteroMedics Announces Publication of Three-Year Data from vBloc Diabetic Patient Study in Journal of Diabetes and Obesity 67

8 Appendix 69

  • 8.1 Research Methodology 70
    • 8.1.1 Coverage 70
    • 8.1.2 Secondary Research 70
    • 8.1.3 Primary Research 71
    • 8.1.4 Market Modeling and Forecasting 72
    • 8.1.5 Company Share Analysis 73
    • 8.1.6 Distribution Share Analysis 74
    • 7.1.7 Benchmarking 74
  • 8.2 GlobalData Consulting 74
  • 8.3 Contact Us 75
  • 8.4 Disclaimer 75

List of Tables

1.1 List of Tables

  • Table 1: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 9
  • Table 2: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 11
  • Table 3: Bariatric Surgery Devices Market, United States, Volume (Units), Historic, 2009-2016 13
  • Table 4: Bariatric Surgery Devices Market, United States, Volume (Units), Forecast, 2016-2023 15
  • Table 5: Bariatric Surgery Devices Market, United States, Average Price ($), Historic, 2009-2016 16
  • Table 6: Bariatric Surgery Devices Market, United States, Average Price ($), Forecast, 2016-2023 16
  • Table 7: Bariatric Surgery Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016 17
  • Table 8: Bariatric Surgery Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 18
  • Table 9: Bariatric Surgery Devices Market Pipeline Products 20
  • Table 10: Allergan to Acquire Zeltiq Aesthetics for USD2.48 Billion 21
  • Table 11: Confluent Medical Technologies Acquires ETE Medical 23
  • Table 12: EnteroMedics Raises USD19 Million in Public Offering of Units 25
  • Table 13: TransEnterix Plans to Raise up to USD25 Million in Private Placement of Shares 27
  • Table 14: GI Dynamics to Raise up to USD0.7 Million in Security Purchase Plan of CDIs 28
  • Table 15: Obalon Therapeutics Prices IPO for USD75 Million 29
  • Table 16: Reshape Medical Raises USD11 Million in Venture Financing 31
  • Table 17: Allurion Tech Raises USD19 Million in Venture Financing 32
  • Table 18: MetaModix Raises USD0.1 Million in Venture Financing 33
  • Table 19: Standard Bariatrics Raises Funds through Seed Financing 34
  • Table 20: Aspire Bariatrics Raises USD3.6 Million in Venture Financing 35
  • Table 21: MetaModix Raises USD0.1 Million in Financing 36
  • Table 22: Total Number of Primary Research Participants, General Surgery Market, by Country 72

List of Figures

1.2 List of Figures

  • Figure 1: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 8
  • Figure 2: Bariatric Surgery Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 10
  • Figure 3: Bariatric Surgery Devices Market, United States, Volume (Units), Historic, 2009-2016 12
  • Figure 4: Bariatric Surgery Devices Market, United States, Volume (Units), Forecast, 2016-2023 14
  • Figure 5: Bariatric Surgery Devices Market, United States, Company Share (%) 2016 18
Back to Top